Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dodick

Showing results (221-230 of 365) with videos related to

Pageof 37
Sort By:
Cephalalgia : an International Journal of Headache|February 9, 2019
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) studyDavid W Dodick, Michael L Reed, Kristina M Fanning, et al.
Cephalalgia : an International Journal of Headache|February 22, 2021
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headacheCaroline M Kopruszinski, Joelle M Turnes, Juliana Swiokla, et al.
Cephalalgia : an International Journal of Headache|November 17, 2021
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraineNikita Chhabra, Chia-Chun Chiang, Marie A Di Nome, et al.
Neurology|November 2, 2012
Migraine headache is present in the aura phase: a prospective studyJakob M Hansen, Richard B Lipton, David W Dodick, et al.
Pain|June 16, 2026
Sexually dimorphic mediation of experimental post-traumatic headache by orexin receptor signalingRobson C Lillo Vizin, Caroline M Kopruszinski, Grace Lee, et al.
The American Journal of Managed Care|November 17, 2017
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendationsStephen D Silberstein, Anne H Calhoun, Christina Treppendahl, et al.
The Neurologist|September 2, 2011
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topicAmaal J Starling, Charlene Hoffman-Snyder, Rashmi B Halker, et al.
Pain|January 10, 2023
Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic primingCaroline M Kopruszinski, Moe Watanabe, Ashley L Martinez, et al.
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Pageof 37

Showing results (221-230 of 365) with videos related to

Sort By:
Pageof 37
Cephalalgia : an International Journal of Headache|February 9, 2019
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) studyDavid W Dodick, Michael L Reed, Kristina M Fanning, et al.
Cephalalgia : an International Journal of Headache|February 22, 2021
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headacheCaroline M Kopruszinski, Joelle M Turnes, Juliana Swiokla, et al.
Cephalalgia : an International Journal of Headache|November 17, 2021
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraineNikita Chhabra, Chia-Chun Chiang, Marie A Di Nome, et al.
Neurology|November 2, 2012
Migraine headache is present in the aura phase: a prospective studyJakob M Hansen, Richard B Lipton, David W Dodick, et al.
Pain|June 16, 2026
Sexually dimorphic mediation of experimental post-traumatic headache by orexin receptor signalingRobson C Lillo Vizin, Caroline M Kopruszinski, Grace Lee, et al.
The American Journal of Managed Care|November 17, 2017
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendationsStephen D Silberstein, Anne H Calhoun, Christina Treppendahl, et al.
The Neurologist|September 2, 2011
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topicAmaal J Starling, Charlene Hoffman-Snyder, Rashmi B Halker, et al.
Pain|January 10, 2023
Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic primingCaroline M Kopruszinski, Moe Watanabe, Ashley L Martinez, et al.
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Pageof 37